9:14Long-form

[ 바이젠셀 ] 긴급속보 임상2상 조건부허가 내년 신청 성공시 매출 1200억! 지금이 기회다 #바이젠셀주가 #바이젠셀주가전망

South KoreaPublished December 5, 2025

Views 53  |  Likes 30  |  Comments 0
Views#2,427,781Global
Views#68,437South Korea

Channel

세력의소문세력의소문
15.1K subs2.48K videosNov 2022

At a glance

Views

53

Likes

30

Comments

0

Performance vs. channel

Outlier score

Engagement rate

Revenue estimate

Details →

Total (all-time): $0 – $0

Based on estimated $0.7–$2 CPM.

About

#바이젠셀 #바이젠셀전망 #바이젠셀주식 #바이젠셀주식전망 #바이젠셀분석

Published
December 5, 2025
Made for kids
No

More features coming

We're working on new analytics and tools. Stay tuned.